Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change
02/07/26	EUR 0.6330	+7.65%
01/07/26	EUR 0.5880	-1.18%
30/06/26	EUR 0.5950	0.00%
29/06/26	EUR 0.5950	-4.19%
26/06/26	EUR 0.6210	+0.16%

Delayed Quote Deutsche Boerse AG

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Delayed Deutsche Boerse AG Other stock markets 04:01:23 02/07/26 pm AEST			5-day change	1st Jan Change
0.6330 ^EUR	+7.65%		+2.10%	-

19/06	Claude Lenoir appointed interim chairman of Theraclion
19/06	Theraclion Chairman Steps Down; Interim Successor Named	MT

Market Cap	49.2M 56.31M 45.18M 42.13M 79.88M 5.36B 81.22M 544M 211M 2.63B 211M 207M 9.06B	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	57.05M 65.29M 52.39M 48.86M 92.62M 6.22B 94.19M 631M 244M 3.05B 245M 240M 10.51B	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	54.37%	Yield 2024 *	-	Yield 2025	-

19/06	Claude Lenoir appointed interim chairman of Theraclion
19/06	Theraclion Chairman Steps Down; Interim Successor Named	MT
19/06	Theraclion Announces Board Changes	CI
09/06	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
05/06	Theraclion deploys first Sonovein system in China
05/06	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
05/06	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
05/06	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
02/06	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
11/05	Bouygues, Euronext, Vallourec... stocks to watch today in Paris
11/05	Theraclion raises nearly 6 million euros via units with warrants
20/04	France's Theraclion Targets EUR6 Million via Capital Increase	MT
20/04	Casino, Rubis, Sanofi... stocks to watch today in Paris

19/06	Theraclion Announces the Evolution of Its Board of Directors	BU
09/06	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU
05/06	Theraclion Announces First Clinical Deployment of Sonovein® in Hainan, China	BU
02/06	Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein® SpeedPulse Were Presented	BU
11/05	Theraclion : Inside Information / Other news releases	PU

Theraclion Stock Deutsche Boerse AG

Stocks

941

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Course Extremes

Managers and Directors: Theraclion

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

19/06	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer
19/06	Les puces américaines en weekend prolongé
19/06	Claude Lenoir nommé président par intérim de Theraclion
19/06	THERACLION ANNONCE L’ÉVOLUTION DE SON CONSEIL D'ADMINISTRATION
14/06	Agenda des dividendes et des AG France : GTT, Alten et Exail sur les tablettes

1 week	0.59	0.63
1 month	0.59	0.93
Current year	0.44	0.93
1 year	0.44	0.93
3 years	0.44	0.93
5 years	0.44	0.93
10 years	0.44	0.93

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	24/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Gaylord Tallec COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Renaud Saleur BRD	Director/Board Member	-	01/02/2018
Ari Kellen BRD	Director/Board Member	-	13/02/2019
Shawn Langer BRD	Director/Board Member	-	13/02/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	+7.65%	+2.10%	-	-	56.04M
THERMO FISHER SCIENTIFIC, INC.	+2.67%	+4.13%	+23.11%	+1.45%	191B
INTUITIVE SURGICAL, INC.	+4.85%	+5.25%	-22.19%	+25.18%	143B
DANAHER CORPORATION	+2.22%	+2.42%	-2.27%	-16.43%	137B
BOSTON SCIENTIFIC CORPORATION	+5.60%	+2.94%	-56.09%	-15.02%	64B
EDWARDS LIFESCIENCES CORPORATION	+2.11%	+4.73%	+21.99%	+2.70%	52.97B
SIEMENS HEALTHINEERS AG	+1.39%	+1.63%	-26.28%	-31.02%	43.82B
AGILENT TECHNOLOGIES, INC.	-0.10%	-1.41%	+10.72%	+11.96%	37.67B
WATERS CORPORATION	-0.35%	-0.22%	+6.86%	+42.04%	37.13B
GE HEALTHCARE TECHNOLOGIES INC.	+1.08%	+1.04%	-13.80%	-18.68%	29.5B
Average	+2.66%	+2.37%	-6.44%	+0.24%	81.72B
Weighted average by Cap.	+2.75%	+3.37%	-3.25%	+1.22%

	2024	2025
Net sales	830K 950K 762K 711K 1.35M 90.45M 1.37M 9.18M 3.56M 44.37M 3.57M 3.49M 153M	652K 746K 599K 558K 1.06M 71.04M 1.08M 7.21M 2.79M 34.84M 2.8M 2.74M 120M
Net income	-5.76M -6.59M -5.29M -4.93M -9.35M -627M -9.5M -63.65M -24.67M -308M -24.74M -24.2M -1.06B	-5.69M -6.51M -5.22M -4.87M -9.24M -620M -9.39M -62.91M -24.38M -304M -24.45M -23.92M -1.05B
Net Debt	3.41M 3.9M 3.13M 2.92M 5.54M 372M 5.63M 37.71M 14.61M 182M 14.66M 14.34M 628M	7.85M 8.99M 7.21M 6.72M 12.75M 855M 12.96M 86.81M 33.64M 420M 33.74M 33.01M 1.45B